INOVIQ Ltd (ASX:IIQ)
0.2100
-0.0150 (-6.67%)
Jul 17, 2026, 4:10 PM AEST
INOVIQ Market Cap
INOVIQ has a market cap or net worth of 29.56 million as of July 17, 2026. Its market cap has decreased by -32.10% in one year.
Market Cap
29.56M
Enterprise Value
16.03M
Revenue
2.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.21
ChartMarket Cap Chart
Since June 20, 2016, INOVIQ's market cap has increased from 13.25M to 29.56M, an increase of 123.15%. That is a compound annual growth rate of 8.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 29.56M | -45.81% |
| Dec 31, 2025 | 54.55M | -5.02% |
| Dec 31, 2024 | 57.44M | -6.14% |
| Dec 29, 2023 | 61.19M | 3.91% |
| Dec 30, 2022 | 58.89M | -46.44% |
| Dec 31, 2021 | 109.96M | 102.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 437.83M |
| Healius | 272.31M |
| Monash IVF Group | 268.85M |
| Cryosite | 63.45M |
| Rhythm Biosciences | 30.79M |
| BCAL Diagnostics | 29.13M |
| Microba Life Sciences | 26.79M |
| ImExHS | 16.76M |